- Home
- BDRX vs IPST Comparison
BDRX vs IPST Comparison
Compare BDRX & IPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | IPST |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.8M |
| IPO Year | 2015 | 2024 |
Fundamental Metrics
Financial Performance| Metric | BDRX | IPST |
|---|---|---|
| Price | $1.27 | $9.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $164.00 |
| AVG Volume (30 Days) | 46.0K | ★ 4.3M |
| Earning Date | 09-12-2025 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,402,488.00 |
| Revenue This Year | N/A | $70.16 |
| Revenue Next Year | N/A | $60.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.41 |
| 52 Week Low | $0.60 | $0.24 |
| 52 Week High | $11.88 | $25.34 |
Technical Indicators
Market Signals| Indicator | BDRX | IPST |
|---|---|---|
| Relative Strength Index (RSI) | 29.78 | 62.76 |
| Support Level | $1.03 | $1.67 |
| Resistance Level | $1.50 | $10.68 |
| Average True Range (ATR) | 0.19 | 3.07 |
| MACD | 0.02 | 0.91 |
| Stochastic Oscillator | 19.23 | 32.65 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.